ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 637729 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 637729; 2) Community: the network communities that were significantly associated with the response to NSC 637729; 3) Molecule: the relationships between components within communities and NSC 637729; 4) MDR: the compounds that were significantly associated with the NSC 637729.

NSC Compound Enrichment Correlation
NSC 107043 Null 0.0430505868034761 0.64390645
NSC 119754 Berbinium, 7,8,13,13a-tetradehydro-2,3:9,10-bis(methylenedioxy)-, chloride (8CI) 0.0430505868034761 0.59696158
NSC 121868 Null 0.0430505868034761 0.19029472
NSC 135073 WITHACNISTIN 0.0430505868034761 0.078967873
NSC 165572 Pyrido[3,2-g]quinoline-2,5,8,10(1H,9H)-tetrone, 1,4,6-trimethyl- 0.0430505868034761 0.44558358
NSC 176323 Camptothecin Derivative 0.0430505868034761 0.13660692
NSC 201873 Null 0.0430505868034761 0.32915759
NSC 287069 Epicorazine A 0.0430505868034761 0.040152231
NSC 295426 Propanoic acid, 2-methyl-, 2,3,3a,4,5,8,9,11a-octahydro-6,10-bis(hydroxymethyl)-3-methylene-2-oxocyclodeca[b]furan-4-yl ester, [3aR-(3aR*,4S*,6Z,10Z,11aR*)]- (9CI) 0.0430505868034761 -0.044276493
NSC 330507 Tanespimycin 0.0430505868034761 0.34143098
Total:61  Current:51    [First] [Prev] [Next] [Last]